Publications

Tipirneni R, Karmakar M, O’Malley M, et al. Contribution of Individual- and Neighborhood-Level Social, Demographic, and Health Factors to COVID-19 Hospitalization Outcomes. Ann Intern Med. [Epub ahead of print 22 February 2022]. doi:10.7326/M21-2615. Abstract

Swaminathan, L., Kaatz, S., Chubb, H. et al. Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study. Infect Dis Ther 11, 887–898 (2022). doi.org/10.1007/s40121-022-00615-x. Abstract

Delaney LD, Bicket MC, Hu HM, O'Malley M, McLaughlin E, Flanders SA, Vaughn VM, Waljee JF. Opioid and benzodiazepine prescribing after COVID-19 hospitalization. J Hosp Med. 2022 May 27. doi: 10.1002/jhm.12842. Epub ahead of print. PMID: 35621024. Abstract

Vaughn VM, Ratz D, McLaughlin ES, Horowitz JK, Flanders SA, Middleton EA, Grant PJ, Kaatz S, Barnes GD. Eligibility for Posthospitalization Venous Thromboembolism Prophylaxis in Hospitalized Patients With COVID-19: A Retrospective Cohort Study. J Am Heart Assoc. 2022 Sep 8:e025914. doi: 10.1161/JAHA.122.025914. Epub ahead of print. PMID: 36073649. Abstract

Sutton, N. R., Robinson-Lane, S. G., Yeow, R. Y., Chubb, H. A., Kim, T., & Chopra, V. (2022). Racial and ethnic variation in COVID-19 care, treatment, and outcomes: A retrospective cohort study from the MiCOVID-19 registry. PloS one, 17(11), e0276806. Abstract

Chopra V. When COVID-19 Strikes at Your Hospital. Annals of Internal Medicine. Published online 6 July 2021. doi.org/10.7326/M21-2681. Abstract

Chopra V, Flanders SA, Vaughn V, et al. Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals. BMJ Open 2021;11:e044921. doi:10.1136/ bmjopen-2020-044921. Abstract

Spencer-Segal JL, Smith CA, Slavin A, Sampang L, DiGiovine D, Spencer AE, Zhang Q, Horowitz J, Vaughn VM. Mental health outcomes after hospitalization with or without COVID-19. Gen Hosp Psychiatry. 2021 Sep-Oct;72:152-153. doi: 10.1016/j.genhosppsych.2021.07.004. Epub 2021 Jul 17. Abstract

Prescott HC, Cheng B, Abshire C. et al. Variation in Scheduling and Receipt of Primary Care Follow-up After Hospitalization for COVID-19 in Michigan. J GEN INTERN MED. Published online 14 September 2021. doi.org/10.1007/s11606-021-07116-6. Abstract

Wayne MT, Weng W, O’Malley M, Bozyk P, Doshi MM, Flanders SA, McSparron JI, et al. Variation in COVID-19 disease severity at hospital admission over time and across hospitals. Medicine. Published online 17 September 2021. doi: 10.1097/MD.0000000000027265. Abstract

Sebolt J, Buchinger J, Govindan S. et al. Patterns of vascular access device use and thrombosis outcomes in patients with COVID-19: a pilot multi-site study of Michigan hospitals. J Thromb Thrombolysis. Published online 22 September 2021. doi.org/10.1007/s11239-021-02559-4. Abstract

Robinson-Lane S, Sutton NR, et al. Race, Ethnicity, and 60-Day Outcomes After Hospitalization With COVID-19. JAMDA. Published online 5 October 2021. doi.org/10.1016/j.jamda.2021.08.023. Abstract

Mann CZ, Abshire C, Yost M, Kaatz S, Swaminathan L, Flanders SA, Prescott HC, Gagnon-Bartsch JA. Derivation and external validation of a simple risk score to predict in-hospital mortality in patients hospitalized for COVID-19: A multicenter retrospective cohort study. Medicine (Baltimore). 2021 Oct 8;100(40):e27422. doi: 10.1097/MD.0000000000027422. Abstract

Vaughn V, Dunn G, Horowitz J, McLaughlin E, & Gandhi T. Duties, resources, and burnout of antibiotic stewards during the coronavirus disease 2019 (COVID-19) pandemic. Antimicrobial Stewardship & Healthcare Epidemiology, 1(1), E39. Published online 5 November 2021. doi:10.1017/ash.2021.200. Abstract

Vaughn V, Gandhi T, Petty LA, Patel PK, et al. Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study. Clinical Infectious Diseases. Published online 21 August 2020. doi:10.1093/cid/ciaa1239. Abstract

Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Annals of Internal Medicine. Published online 11 November 2020. doi:10.7326/M20-5661. Abstract

Vaughn VM, Yost M, Abshire C, et al. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19. JAMA Netw Open. 2021;4(6):e2111788. doi:10.1001/jamanetworkopen.2021.11788. Abstract

Schultz MJ, Teng MS, Brenner MJ. Timing of Tracheostomy for Patients With COVID-19 in the ICU—Setting Precedent in Unprecedented Times. JAMA Otolaryngol Head Neck Surg. September 3, 2020;146(10):887–888. doi:10.1001/jamaoto.2020.2630 Abstract

Rothberg MB, Hamilton A, Greene MT, Fox J, Lisheba O, Milinovich A, Gautier TN, Kim P, Kaatz S, Hu B. Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism. Thromb Haemost. Published online 16 November 2021. doi: 10.1055/a-1698-6506. Epub ahead of print. Abstract

Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in Nonsurgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e195S-e226S. Abstract

Phung OJ, Kahn SR, Cook DJ, Murad MH. Dosing frequency of unfractionated heparin thromboprophylaxis. A meta-analysis. Chest. 2011;140:374-381. Abstract

Rothberg MB, Lindenauer PK, Lahti M, Pekow PS, Selker HP. Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med. 2011;6:202-209. Abstract

Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients. Chest. 2011;139:69-79. Abstract

Maynard GA, Morris TA, Jenkins IH, et al. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med. 2010;5:10-18. Abstract

Anderson FA, Goldhaber SZ, Tapson VF et al. Improving practices in US hospitals to prevent venous thromboembolism: Lessons from ENDORSE. Am J Med. 2010;123:1099-1106. Abstract

Rothberg MB, Lahti M, Pekow PS, et al. Venous thromboembolism prophylaxis among medical patients at US hospitals. J Gen Intern Med. 2010:25:489-94. Abstract

Bump GM, Dandu M, Kaufman SR, et al. How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials. J Hosp Med. 2009;4:289-297. Abstract

Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S-453S Abstract

Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007;146:278-288. Abstract

Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332:325-9. Abstract

Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70-78. Abstract

Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352:969-77 Abstract

Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of daltaparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874-879. Abstract

Kleber F, Witt C, Vogel G, et al. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J. 2003;145:614-21. Abstract

Samama MM, Cohen AT, Darmon J, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med. 1999;341:793-800. Abstract